mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Diabetic nephropathy (DN) is among the most lethal complications that occur in type 1 and type 2 diabetics. Podocyte dysfunction is postulated to be a critical event associated with proteinuria and glomerulosclerosis in glomerular diseases including DN. However, molecular mechanisms of podocyte dysfunction in the development of DN are not well understood. Here we have shown that activity of mTOR complex 1 (mTORC1), a kinase that senses nutrient availability, was enhanced in the podocytes of diabetic animals. Further, podocyte-specific mTORC1 activation induced by ablation of an upstream negative regulator (PcKOTsc1) recapitulated many DN features, including podocyte loss, glomerular basement membrane thickening, mesangial expansion, and proteinuria in nondiabetic young and adult mice. Abnormal mTORC1 activation caused mislocalization of slit diaphragm proteins and induced an epithelial-mesenchymal transition-like phenotypic switch with enhanced ER stress in podocytes. Conversely, reduction of ER stress with a chemical chaperone significantly protected against both the podocyte phenotypic switch and podocyte loss in PcKOTsc1 mice. Finally, genetic reduction of podocyte-specific mTORC1 in diabetic animals suppressed the development of DN. These results indicate that mTORC1 activation in podocytes is a critical event in inducing DN and suggest that reduction of podocyte mTORC1 activity is a potential therapeutic strategy to prevent DN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although podocytes have high basal levels of autophagy, high mTORC1 activity is also required for these cells to maintain their function”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ulianich, L., Garbi, C., Treglia, A. S., Punzi, D., Miele, C., Raciti, G. A., Bèguinot, F., Consiglio, E., & Jeso, B. D. (2008) · Journal of Cell Science · doi:10.1242/jcs.017202 · Cited by 114
RetractedTOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Self-citationUpstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Self-citationThe Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Self-citationKestilä, M., Lenkkeri, U., Männikkö, M., Lamerdin, J., McCready, P., Putaala, H., Ruotsalainen, V., Morita, T., Nissinen, M., Herva, R., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80057-x · Cited by 1,866
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M.-C., Niaudet, P., & Antignac, C. (2000) · Nature Genetics · doi:10.1038/74166 · Cited by 1,444
Research works printed but not linked: 2
- Zhong, Am J Respir Cell Mol Biol.
- Kouraklis, 2006, Oncol Rep., 15, 489
Cited by
Items 501–544 of 544
Screening for Molecules That Bind to lhx1a
Adeeb, B. (2017)
Regulation and Functions of Cardiac Lipins
Kok, B. P. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r30b09
Overview of Autophagy and Cardiometabolic Syndrome
Aroor, A. R., Jia, G., & Sowers, J. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805253-2.00001-8
Efecto protector de la cardiotrofina-1 en la fibrosis tubulointersticial y glomerulonefritis
Perretta‐Tejedor, N. (2017) · Gredos (University of Salamanca) · doi:10.14201/gredos.137128
TGF-β-induced pathogenic changes in mouse podocytes
Das, R. (2014) · YUHSpace (Yonsei University Medical Library)
Insights into Glomerular Cell Biology in Health and Disease
Alghamdi, T. A. (2019) · TSpace (University of Toronto)
Hwanggeum-tang Water Extracts Suppress TGF-β1 Induced EMT in Podocyte
Shin, S. W., & Jeong, H.-S. (2020) · 동의생리병리학회지 · doi:10.15188/kjopp.2020.04.34.2.61
Meng, R., Cao, Y., Khoso, M. H., Kang, K., Ren, G., Xiao, W. L., & Li, D. (2020) · doi:10.21203/rs.3.rs-118596/v1
“The most common negative regulation 83 signaling pathway is mTOR [13].”
BackgroundNutrition and Diet Therapy for DKD
Kume, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-9301-7_7
Molecular Mechanisms of Apoptosis of Glomerular Podocytes in Diabetic Nephropathy
Shpakov, A. O., & Kaznacheyeva, E. V. (2020) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747820030058
К вопросу об особой правовой ментальности русского народа
Мусаелян, Л. А. (2011) · Вестник Пермского университета Юридические науки
Bouvier, N. (2012) · theses.fr (ABES) · doi:10.70675/1357c585z7fa8z4b40za8aczf65762ade602
“, through secretion of vasoactive compounds, such as endothelin 1, leading to tissue ischemia) of CNI nephrotoxicity (29).”
BackgroundRuilope, L. M., & Morales, E. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737697188.793573300
Cybulsky, A. V. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739567860.793588958
ECELBARGER, C. A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732790761.793546067
(2011) · Kidney International · doi:10.1038/ki.2011.215
Progression des maladies rénales chroniques : Rôle de la voie AKT/mTORC
Canaud, G. (2012) · theses.fr (ABES) · doi:10.70675/b6df71c8ze03dz4d0fz8253z77de19fe3150
The Emerging Importance of Cellular Insulin Resistance in Diabetic Kidney Disease
Coward, R. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00272-8
The Role of Autophagy in Renal Fibrosis
解, 雅. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12111515
Samaan, E., Ahmed, S., Sheashaa, H., Ibrahim, D. A., & Sayed‐Ahmed, N. (2023) · Journal of The Egyptian Society of Nephrology and Transplantation · doi:10.4103/jesnt.jesnt_15_23
Nutrition for Podocyte Repair in Nephrotic Syndrome?
Aquilani, R., & Verri, M. (2023) · Nutrients · doi:10.3390/nu15214615
Modulation et monitoring de l'activité de l'axe IRE1α-XBP1 au cours de la réponse UPR
Tavernier, Q. (2018) · theses.fr (ABES) · doi:10.70675/20a59b12zfdc4z4ed3zb9b2z37639daf3e31
Junli, W., Zhihong, H., Lina, W., Qiaoqun, O., Jing, Q., Jiaqi, H., & Yu, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1488340
“MTORC1 hyperactivation stimulates ERS-and EMT-like phenotypes in podocytes, which ultimately leads to podocyte weakness, and decreasing podocyte mTORC1 activity is a potential therapeutic strategy to prevent DN (Inoki et al., 2011).”
Mechanisms of Podocyte Injury in Kidney Allografts
Barsotti, G. C., Menon, M. C., Naik, A. S., & Rao, A. (2025) · Kidney360 · doi:10.34067/kid.0000001091
“33,146 Podocyte mTOR activation has been observed with diabetic nephropathy, 147 and excess podocyte-speci fi c mTOR activation alone induced FSGS. 33 Controlled inhibition of mTORC1 can mitigate maladaptive hypertrophy and restore autophagic fl ux under stress conditions.”
Role of murine double minute (MDM)-2 in kidney injury and repair
Mulay, S. R. (2013) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.15768 · Cited by 1
Chen, F., Sheng, L., Zhou, T., Yan, L., Loveless, R., Li, H., Teng, Y., & Cai, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22735398
Watany, M. M., El‐Horany, H. E., Elhosary, M. M., & Elhadidy, A. A. (2023) · Figshare · doi:10.6084/m9.figshare.22615484
Circadian Medicine: Pioneering Translational Applications from Human to Veterinary Clinical Care
Farag, H. (2022) · The Atrium (University of Guelph)
Depletion of Flot1 attenuates macropinosome-dependent mTORC1 activation in podocytes
Li, Y., He, Y., Cheng, L., Yang, H., Wang, X., Mimuro, H., Fu, Y., & Yoshida, S. (2026) · Cell Structure and Function · doi:10.1247/csf.25156
Self-citationZaini, L. M., Syukri, M., Kartasasmita, A., Gondhowiardjo, T. D., & Lesmana, R. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1013249
Fukushima, K., Tsuji, K., Nakanoh, H., Uchida, N., Kitamura, S., & Wada, J. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.104642
富田, 一., Tomita, I., 菅原, 翔., 大澤, 紀., 山原, 康., 山原, 真., Takeda, N., 金崎, 雅., 扇田, 久., 荒木, 信., et al. (2020) · Institutional Repositories DataBase (IRDB)
Neuropathic injury : new insights on NADPH oxidases in diabetic neuropathy
Eid, S. (2017) · theses.fr (ABES) · doi:10.70675/d5be110dzf78bz46a3z96b1zcb23d1eae233
Étude du syndrome néphrotique idiopathique par des approches protéomiques
Chhuon, C. (2020) · theses.fr (ABES) · doi:10.70675/48a7b91bzd278z4676z99c6z4bbf94447a5c
Parietal epithelial cells and their role in focal segmental glomerulosclerosis
van der Miesen, L. (2022) · Radboud Repository (Radboud University)
Dong, W., Wang, X., Gong, Z., Gao, S., Zheng, H., Dong, G., Zhao, P., Chen, F., & Liu, Z. (2026) · Journal of Environmental Sciences · doi:10.1016/j.jes.2026.05.046
岩田, 和. (2020) · Institutional Repositories DataBase (IRDB)
Xu, J., Shi, J., Hu, P., Jiang, N., Zhong, J., Shao, G., Zhu, S., Gu, Y., Jia, W., Cheng, G., et al. (2026) · Diabetes · doi:10.2337/db25-0883
Franco, M. L., Beyerstedt, S., Barbosa¹, B. S., Alves, T. M. R., Silva, A. F. D., Mariano, M. O., Carlos, A. K., Arjona, J. E., Josefi-Rocha, G. R., Bastos, R. M. C., et al. (2026) · Stem Cells · doi:10.1093/stmcls/sxag043
Xuan, J., Ding, R., Zhang, H., Wang, Y., Wu, L., Liu, Y., Dong, J., & Hu, R. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1951798
“…Inoki et al., 2011), (Gödel et al., 2011), (Welsh et al., 2010), (Hartleben et al., 2010)) AKT2, mTORC2, and basal autophagy support Inoki et al., 2011), (Gödel et al., 2011), (Eid et al., 2013), (Hartleben et al., 2010; Lindenmeyer et al., 2008; Vollenbröker et al., 2009; Wang et…”
InfluentialAbelmoschus manihot in Chronic Kidney Disease: Evidence-Based Therapeutics and Mechanistic Insights
Sun, S., Qiao, L., Zhao, J., Tang, H., Luo, Y., Tao, Y., 陈崇, & Sun, W. (2026) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2026.151723
Sureshkumar, S., Espitia, C. M., Bi, F., Xiong, R., Gamble, M. E., Hakim, N. L., Kelly, K. R., Carew, J. S., & Nawrocki, S. T. (2026) · Cancers · doi:10.3390/cancers18203358
“Aberrant mTORC1 and insulin-like growth factor signaling further contribute to the pathological response of the kidney to metabolic stress [112,113].”
Podocytes: Key Effectors of Glomerular Permeability and Structural Integrity
Alamilla-Sanchez, M., Galván, V. U., Estrella, B. Y., Cuevas, J. L. T., Zárate, M. C., Maure, M. S., Pineda, D. D., & Palafox, O. L. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016268
Interplay between autophagy and the primary cilium : Role in mechanical stress integration
Orhon, I. (2014) · theses.fr (ABES) · doi:10.70675/5a8e38fdzffc8z4a05za2edz90c5149785de
Metadata
- Authors
- Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Rüegg, M. A., Hall, M. N., Kwiatkowski, D. J., Rastaldi, M. P., Huber, T. B., Kretzler, M., Holzman, L. B., Wiggins, R. C., & Guan, K.-L.
- Affiliations
- University of Michigan (US)
- Life Sciences Institute (SG)
- University of Basel (CH)
- Harvard University (US)
- Brigham and Women's Hospital (US)
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
- University of California San Diego (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-06-01
- Volume
- 121
- Issue
- 6
- Pages
- 2181-2196
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3104745
- OpenAlex
- W2033798110
- Cited by
- 538
- References
- 77
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 23 · 2023: 36 · 2022: 33 · 2021: 22 · 2020: 48 · 2019: 43 · 2018: 39 · 2017: 39 · 2016: 39 · 2015: 35 · 2014: 44 · 2013: 45 · 2012: 36
- FWCI
- 35.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion)
- edoc (University of Basel)
- Funders
- National Institutes of Health (5r01dk083491-09, DK083491)
- National Cancer Institute (R01CA108941)
- National Institute of General Medical Sciences (R01GM051586, GM051586)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK083491, DK-083491, R01DK124709)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Oncology › Renal and related cancers
- Keywords
- diabetic nephropathy, mTORC1, podocytes, podocyte loss, proteinuria, glomerulosclerosis, endoplasmic reticulum stress, epithelial-mesenchymal transition, slit diaphragm proteins, TSC1, chemical chaperones, mesangial expansion, glomerular basement membrane thickening
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Regulatory-Associated Protein of mTOR, Tuberous Sclerosis Complex 1 Protein, Animals, Carrier Proteins, Cell Differentiation, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Disease Models, Animal, Endoplasmic Reticulum, Enzyme Activation, Glomerular Mesangium, Male, Membrane Proteins, Mice, Inbred C57BL, Mice, Mutant Strains, Phosphorylation, Protein Processing, Post-Translational, Proteins, Mice, Knockout, Ribosomal Protein S6 Kinases, Sirolimus, Tumor Suppressor Proteins, Multiprotein Complexes, Adaptor Proteins, Signal Transducing, Podocytes, Glomerular Basement Membrane, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.